Xinling Liang
Overview
Explore the profile of Xinling Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang T, Li L, Chen Y, Zhang L, Xu L, Li Z, et al.
Nan Fang Yi Ke Da Xue Xue Bao
. 2025 Mar;
45(2):379-386.
PMID: 40031982
Objectives: To explore the value of serum cystatin C (CysC) levels in evaluating renal prognosis in IgA nephropathy (IgAN) patients. Methods: We retrospectively collected the clinical data of IgAN patients...
2.
Li L, Zhang L, Cai Y, Li J, Zheng S, Wang W, et al.
Front Cell Dev Biol
. 2024 Dec;
12:1457369.
PMID: 39659523
Pyroptosis is one of the ways to cause proximal tubular epithelial cell death in diabetic nephropathy (DN), but the exact mechanism remains unclear. Absent in melanoma 2 (AIM2), a sensor...
3.
Hu P, Liang H, Zhao Z, Chu H, Mo Z, Song L, et al.
Ren Fail
. 2024 Dec;
46(2):2417744.
PMID: 39622314
Background: Inflammation is one of the important pathophysiological characteristics of acute kidney injury (AKI) after cardiac surgery. The aim was to explore the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR), a...
4.
Zhao X, Karaboyas A, Gan L, Hou F, Liang X, Chen X, et al.
Sci Rep
. 2024 Nov;
14(1):26572.
PMID: 39496692
Our previous manuscript showed that thrombocytopenia predicts all-cause mortality in Chinese hemodialysis (HD) patients. Based on the role of platelets in coagulation, clot formation, and systemic inflammation, we speculate that...
5.
Shi Q, Xiao Z, Cai W, Chen Y, Liang H, Ye Z, et al.
Biochem Biophys Res Commun
. 2024 Sep;
733:150630.
PMID: 39332154
Mitochondrial dysfunction contributes to septic acute kidney injury (S-AKI), making mitochondrial protection a potential therapeutic strategy. This study investigates the effects of S14G-humanin (HNG) in S-AKI, utilizing 4D-label-free and parallel...
6.
Li J, Yang Y, Li L, Zheng S, Zhang H, Li C, et al.
Eur J Pharmacol
. 2024 Sep;
983:177007.
PMID: 39307335
Background: Autophagy plays an important role in the pathogenesis of focal segmental glomerulosclerosis (FSGS). Podocyte-specific Yes-associated protein (YAP) deletion mice, referred to as YAP-KO mice, is considered a new animal...
7.
Zhang F, Xie Z, Peng S, Jiang N, Li B, Chen B, et al.
Nephrology (Carlton)
. 2024 Sep;
29(11):729-737.
PMID: 39254037
Aim: IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. Pregnant IgAN patients are more susceptible to adverse pregnancy outcomes (APO). However, the risk factor for APO and...
8.
Liang X, Lu W, Yu X, Cheng H, He Q, Peng Q, et al.
Clin Ther
. 2024 Aug;
46(9):702-710.
PMID: 39112102
Purpose: Sodium zirconium cyclosilicate (SZC) is an oral potassium (K)-lowering therapy for adults with hyperkalemia. HARMONIZE Asia (ClinicalTrials.gov identifier: NCT03528681) evaluated the efficacy and safety of SZC in Chinese patients...
9.
Zhao X, Gan L, Hou F, Liang X, Chen X, Chen Y, et al.
Ren Fail
. 2024 Jan;
46(1):2290922.
PMID: 38234178
Anemia is a common complication of chronic kidney disease with major option treatment of erythropoiesis-stimulating agents (ESAs). This study aimed to investigate the influencing factors of erythropoietin resistance index (ERI)...
10.
Ni Z, Liang X, Wu C, Jin K, Kim Y, Lu K, et al.
Kidney Int Rep
. 2023 Nov;
8(11):2294-2306.
PMID: 38025238
Introduction: Evocalcet is an oral calcimimetic agent with proven efficacy and safety in treating secondary hyperparathyroidism (SHPT) in Japanese patients on dialysis. Methods: This randomized, double-blind, intrapatient dose-adjustment, parallel-group, international...